LEVOFLOXACIN — all Canadian products
13 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is LEVOFLOXACIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02537079 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | HIKMA CANADA LIMITED | Solution | Intravenous | LEVOFLOXACIN 5 MG | Marketed | |
| 02460122 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | STERIMAX INC | Solution | Intravenous | LEVOFLOXACIN 5 MG | Approved | |
| 02314932 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | PFIZER CANADA ULC | Solution | Intravenous | LEVOFLOXACIN 5 MG | Marketed | |
| 02361035 | AVA-LEVOFLOXACIN | AVANSTRA INC | Tablet | Oral | LEVOFLOXACIN 500 MG | Cancelled Post Market | |
| 02361027 | AVA-LEVOFLOXACIN | AVANSTRA INC | Tablet | Oral | LEVOFLOXACIN 250 MG | Cancelled Post Market | |
| 02236841 | LEVAQUIN | JANSSEN INC | Tablet | Oral | LEVOFLOXACIN 250 MG | Cancelled Post Market | |
| 02236840 | LEVAQUIN 25MG/ML | JANSSEN INC | Solution | Intravenous | LEVOFLOXACIN 25 MG | Cancelled Post Market | |
| 02236842 | LEVAQUIN 500MG | JANSSEN INC | Tablet | Oral | LEVOFLOXACIN 500 MG | Cancelled Post Market | |
| 02236839 | LEVAQUIN 5MG/ML | JANSSEN INC | Solution | Intravenous | LEVOFLOXACIN 5 MG | Cancelled Post Market | |
| 02246804 | LEVAQUIN 750MG | JANSSEN INC | Tablet | Oral | LEVOFLOXACIN 750 MG | Cancelled Post Market | |
| 02358670 | NTP-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | Oral | LEVOFLOXACIN 750 MG | Cancelled Pre Market | |
| 02358662 | NTP-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | Oral | LEVOFLOXACIN 500 MG | Cancelled Pre Market | |
| 02358654 | NTP-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | Oral | LEVOFLOXACIN 250 MG | Cancelled Pre Market |
Browse other molecules: